Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. (ELTP) Stock Overview
Explore Elite Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
427.1M
P/E Ratio
9.90
EPS (TTM)
$0.02
ROE
0.71%
ELTP Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Elite Pharmaceuticals, Inc. (ELTP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.79.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.90 and a market capitalization of 427.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.